Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Trepo

Showing results (311-320 of 334) with videos related to

Pageof 34
Sort By:
HIV Medicine|February 27, 2008
Pneumococcal pneumonia in HIV-infected patients by antiretroviral therapy periodsM Saindou, C Chidiac, P Miailhes, et al.
Scandinavian Journal of Gastroenterology|May 5, 2001
Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcomeJ Dumortier, T Bizollon, J Y Scoazec, et al.
Antiviral Therapy|August 9, 2001
Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatmentW Rozenbaum, C Katlama, P Massip, et al.
Journal of Viral Hepatitis|September 19, 2007
Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohortT Bénet, A D'Oliveira, N Voirin, et al.
Lancet (London, England)|October 30, 1982
Influence of delta infection on severity of hepatitis BA Smedile, P Farci, G Verme, et al.
European Journal of Gastroenterology & Hepatology|May 8, 2001
Transjugular intra-hepatic portosystemic shunt for refractory variceal bleedingT Bizollon, J Dumortier, C Jouisse, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
Gene Therapy|June 26, 2001
Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liverM Robaczewska, S Guerret, J S Remy, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987
Unexpected low prevalence of delta antibodies in the east Amazon region and São Paulo: evidence for regional differences in the epidemiology of delta hepatitis virus within BrazilE Strauss, L C Gayotto, L C da Silva, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatmentD C Valla, M Chevallier, P Marcellin, et al.
Pageof 34

Showing results (311-320 of 334) with videos related to

Sort By:
Pageof 34
HIV Medicine|February 27, 2008
Pneumococcal pneumonia in HIV-infected patients by antiretroviral therapy periodsM Saindou, C Chidiac, P Miailhes, et al.
Scandinavian Journal of Gastroenterology|May 5, 2001
Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcomeJ Dumortier, T Bizollon, J Y Scoazec, et al.
Antiviral Therapy|August 9, 2001
Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatmentW Rozenbaum, C Katlama, P Massip, et al.
Journal of Viral Hepatitis|September 19, 2007
Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohortT Bénet, A D'Oliveira, N Voirin, et al.
Lancet (London, England)|October 30, 1982
Influence of delta infection on severity of hepatitis BA Smedile, P Farci, G Verme, et al.
European Journal of Gastroenterology & Hepatology|May 8, 2001
Transjugular intra-hepatic portosystemic shunt for refractory variceal bleedingT Bizollon, J Dumortier, C Jouisse, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
Gene Therapy|June 26, 2001
Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liverM Robaczewska, S Guerret, J S Remy, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987
Unexpected low prevalence of delta antibodies in the east Amazon region and São Paulo: evidence for regional differences in the epidemiology of delta hepatitis virus within BrazilE Strauss, L C Gayotto, L C da Silva, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatmentD C Valla, M Chevallier, P Marcellin, et al.
Pageof 34